Clinical trial

Bone Mineral Density (BMD) in HIV Infection

NCT00146094 · University Hospital, Strasbourg, France, Other · Terminated

Key facts

NCT number NCT00146094
Title Bone Mineral Density (BMD) in HIV Infection
Official title Osteopenia and Osteoporosis in HIV Infection. Prospective BMD Measurement in Antiretroviral (ARV) Treated and Untreated HIV-1 Infected Patients
Lead sponsor University Hospital, Strasbourg, France, Other
Status Terminated
Study type Interventional
Conditions Osteopenia, Osteoporosis
Intervention type Drug, Procedure
Interventions BMD Measurement, antiretrovirals
Enrollment 44
Start date Mar 1, 2003
Primary completion Mar 1, 2003
Completion Dec 14, 2006
First posted Sep 5, 2005
Last update posted Sep 26, 2025
Countries France

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies